The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports

Expert Says Health Tech Co. Is in Another Buy Spot

Contributed Opinion
  ()
Expert Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you why he believes it is in another buy spot.

Expert Says Health Tech Co. Still in Good Spot To Buy

Contributed Opinion
  ()
Technical analyst Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you whether he believes it is a Buy.

Telemedicine Co. Surges on Revenue News

  ()
As internet-enabled health care becomes more accepted in the wake of the pandemic, telemedicine company Reliq Health Technologies Inc. is seeing its revenue soar.

Telemedicine Co. Says It's Set To Thrive in Post-Pandemic World

  ()
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc.

US Co. To Regain All Rights to Its AGHD Diagnostic Test

Research Report
  ()
This is set to happen because the biopharma's commercialization partner recently terminated its agreement over the product, noted an H.C. Wainwright & Co. report.

Expert Expects Life Science Co. To Do Exceptionally Well

  ()
Avivagen is an early-stage life sciences company with a patented product for immune support that causes dramatic and profitable improvements in livestock. They have been increasing their sales and market penetration at a dramatic rate, and I believe them to be at an inflection point. Research coverage is expecting a 7x return.

MRI Device Maker's Earnings Come In at High End of Forecasts

Research Report
  ()
IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins, and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40).

Monkeypox Virus Test Could Yield Revenue for Its Creator

Research Report
  ()
The Utah-based diagnostics firm has multiple shots on goal with this specific molecular test and with its convenient, fast testing platform, both in development, noted an H.C. Wainwright & Co. report.

Showing Results: 1 to 12 of 12